The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of tumor progression among patients with glioma after COVID-19 infection.
 
Tim Gregory
No Relationships to Disclose
 
Stephanie Knight
No Relationships to Disclose
 
Ashley Aaroe
No Relationships to Disclose
 
Barbara Jane O'Brien
Consulting or Advisory Role - Plus Therapeutics
Research Funding - EMD Serono (Inst); Kintara (Inst)
 
Chirag B Patel
Consulting or Advisory Role - Novocure
Research Funding - Novocure (Inst)
Patents, Royalties, Other Intellectual Property - Patent application with Novocure, Ltd.
Travel, Accommodations, Expenses - Abbvie; Novocure
(OPTIONAL) Uncompensated Relationships - BMC Neuroscience; National Brain Tumor Registry of China (NBTRC)
 
Shiao-Pei S. Weathers
Research Funding - Exelixis; Genentech/Roche (Inst); Mundipharma (Inst)
 
Nazanin Majd
Consulting or Advisory Role - Baxter (I); Celularity; Sumitomo Dainippon Pharma Co., Ltd. Consulting
 
Vinay K. Puduvalli
Stock and Other Ownership Interests - Amarin Corporation; Gilead Sciences
Honoraria - InSightec; Novocure; Orbus Therapeutics; SERVIER
Consulting or Advisory Role - InSightec; Newave Pharmaceutical (I); NewBio; Novocure; Orbus Therapeutics; SERVIER
Research Funding - Bexion; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Merck; Radiomedix; Samus Therapeutics; SERVIER
 
Carlos Kamiya-Matsuoka
No Relationships to Disclose